Healthcare Success

JULY 5, 2022

(Editor’s Note: I wrote the first version of this blog post back in 2006 when we launched Healthcare Success. Every time I run into someone who is faced with the daunting challenge of marketing to doctors or other healthcare professionals, I giggle empathetically and say, “I feel your pain.”. Conclusion.

Doctors 57

Doctors Physicians Marketing Healthcare 57

Pharmaceutical Technology

MARCH 24, 2023

Biosimilars are an important tool to facilitate competition, lower the price of drugs, and create savings across the board. Currently, 40 biosimilars are FDA-approved and 25 have launched, whereas the EMA has approved 86 biosimilars since 2006. The biosimilar market in the US may progress differently this time.

Competition 59

Competition Marketing FDA Physicians 59

PM360

SEPTEMBER 28, 2022

Chrys Kokino has been involved in the biosimilars market prior to the first biosimilar being approved in Europe in 2006. From that point in 2006 all the way to where we are currently today, there has been a very dramatic evolution of these products. The level of competition is much greater today then we previously anticipated.

Competition 98

Competition Marketing Manufacturing Biopharma 98

Pharmaceutical Technology

FEBRUARY 24, 2023

The revision process is reviving old conflicts in the pharma industry over fair and affordable access to medicines versus Europe’s status as a competitive home for pharma innovation. EU competitiveness Moll said the legislation revisions should instead be used to make Europe more attractive to pharma companies.

Pharma 64

Pharma Medicine Competition Marketing 64

European Pharmaceutical Review

DECEMBER 19, 2022

European regulators have led the way for the development of biosimilars in the past, with 86 approvals granted since 2006″ European regulators have led the way for the development of biosimilars in the past, with 86 approvals granted since 2006. The Impact of Biosimilar Competition in Europe, IQVIA, December 2021.

Medicine 52

Medicine Biopharma Safety Food 52

Pharmaceutical Technology

OCTOBER 5, 2022

In 2009, former Biogen employee Michael Bawduniak filed a lawsuit claiming that Biogen had violated the False Claims Act and the Anti-Kickback Statute by providing millions of dollars to healthcare providers (HCPs) as an incentive to prescribe three of its multiple sclerosis (MS) drugs. BIIB107 is a monoclonal antibody that targets ?4

Government 59

Government Specialization Physicians Education 59

CloserIQ

OCTOBER 10, 2018

Founded 2006. Founded 2006. Kyruus is revolutionizing healthcare with its data-driven system that makes it easier for healthcare system to match patients to appropriate providers. Cybereason’s workplace culture is known to be fast-paced and competitive, with plenty of opportunities for learning. 251-500 employees.

Sales 76

Sales Management Education Marketing 76

European Pharmaceutical Review

FEBRUARY 7, 2023

Key changes are expected to be proposed in relation to the Community Code on medicinal products, the EMA Regulation 726/2004 (the EU’s general pharmaceuticals legislation), the Orphan Regulation 141/2000 and the Pediatric Regulation 1901/2006.

Medical 117

Medical Government Marketing Medicine 117

Pharmaceutical Technology

JULY 10, 2008

The past Global figures from PwC show that in 2006 only two big pharmaceutical companies earned more than 10% of their revenues from major products that were less than three years old. “In 2006 only two big pharmaceutical companies earned more than 10% of their revenues from major products that were less than three years old.”

Food and Drug Administration 52

Food and Drug Administration Medicine Pharmaceutical Government 52

Pharmaceutical Technology

JULY 23, 2008

“There’s a huge clinical need which has been undelivered for years,” says Gustav Ando, manager of the healthcare business development unit [HBDU] at Global Insight. All those people need treatment, which creates demand for drugs and stimulates growth in the sector. There’s been a huge change in the market.”

Side effects 52

Side effects Marketing Pharmaceutical Sales 52

Evolve Your Success

JANUARY 23, 2024

In 2006 or even a little bit earlier than that, Joel Matta was a very well-known orthopedic surgeon. Sometimes my competition will take that article and say, “I could plus or minus 10 millimeters.” The Caribbean’s got a little difficult to navigate in. Walk us through the process. How did OrthoGrid spawn? What happened?

Medical sales 52

Medical sales Sales Medical Physicians 52

World of DTC Marketing

JUNE 7, 2021

Retail price increases for widely used brand name prescription drugs consistently exceeded the rate of general inflation between 2006 and 2020. Eight US antitrust bills targeting the pharmaceutical industry have been recently introduced, addressing a gamut of alleged anti-competitive activity. percent over the same period.

Pharma 187

Pharma Retail Prescription Competition 187